课题基金 / 基金详情

A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUROLOGICAL DYSF

A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUROLOGICAL DYSF
PN401嘧啶反应性神经病综合征综合征的 II 期研究
批准号：
7606507
负责人：
BRUCE A BARSHOP
金额：
$0.19万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
项目状态：
已结题
起止时间：
2006-12-01 至 2007-11-30
来源：
https://reporter.nih.gov/project-details/7606507
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseFundingGrantInfectionInstitutionLanguageNeurologicNeurologic DysfunctionsPN401 (triacetyluridine)PatientsPhasePredispositionPyrimidinePyrimidinesQuality of lifeResearchResearch PersonnelResourcesSafetySeizuresSigns and SymptomsSourceSpeechSyndromeUnited States National Institutes of Healthcognitive function

项目摘要

项目成果

BRUCE A BARSHOP的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Evaluate safety and efficacy of PN401 in reduction of seizures and infections, improvement of speech and language and cognitive functions in patients with pyrimidine responsive syndrome of neurological dysfunction and susceptibility to infection, evaluate quality of life, and describe effects of PN401 on signs and symptoms of the syndrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CYSTEAMINE BITARTRATE DELAYED-RELESEASE CAPSULES (RP103) COMPARED TO CYSTEAMINE
CLINICAL TRIAL: A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUR
CLINICAL TRIAL: ALGLUCOSIDASE ALFA TEMPORARY ACCESS PROGRAM (ATAP) PROTOCOL AGLU
CLINICAL TRIAL: A PHASE II STUDY OF PN401 PYRIMIDINE RESPONSIVE SYNDROME OF NEUR
海外基金